Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Oritavancin Diphosphate bulk supplier for pharma manufacturers

Oritavancin Diphosphate 400 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 400 mg

Reference Brands: Orbactiv (USA)

Category: Antibiotics

Oritavancin Diphosphate is a Antibiotics product available as Injection in strengths 400 mg. It corresponds to the reference brand Orbactiv (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Oritavancin, marketed under the brand name Orbactiv, is a semisynthetic glycopeptide antibiotic used for the treatment of serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA). Structurally related to vancomycin, it is a lipoglycopeptide that inhibits bacterial cell wall synthesis and disrupts membrane integrity, leading to rapid bacterial cell death.

Oritavancin is considered a long-acting antibiotic due to its extended half-life of up to 16 days and high plasma protein binding (~85%), which allows for sustained therapeutic concentrations in tissues. The drug demonstrates excellent tissue penetration, including skin structures, synovial fluid, bone tissue, and macrophages, making it effective in treating complex infections. Its pharmacokinetic properties enable less frequent dosing while maintaining potent activity against Gram-positive pathogens.

These features make oritavancin a convenient option for outpatient therapy, particularly in populations where adherence may be challenging or access to healthcare is limited. It is suitable for prolonged courses in infections such as osteoarticular infections, endocarditis, and other deep-seated Gram-positive infections. Oritavancin should be administered under specialist supervision to ensure optimal efficacy and patient safety.

Oritavancin Diphosphate — third party manufacturing & bulk supply

Oritavancin Diphosphate 400 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Oritavancin Diphosphate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Oritavancin Diphosphate →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Oritavancin diphosphate is used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including MRSA.

Oritavancin diphosphate is a semisynthetic lipoglycopeptide antibiotic derived from a naturally occurring glycopeptide compound, formulated as a sterile injectable powder.

The trade name is Orbactiv.

Orbactiv is marketed by Melinta Therapeutics (USA).

The complete generic name is oritavancin diphosphate.

The approved brand name is Orbactiv.

Oritavancin diphosphate is manufactured in GMP-approved facilities in the USA and other regulated pharmaceutical manufacturing regions, depending on the authorized supplier.

Related Products

Rifaximin

Strength:
100 mg/5 mL, 200 mg, 550 mg

Form: Tablet / Oral Suspension

Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)

View Details
Ceftaroline

Strength:
600 mg

Form: Injection

Reference Brands: Teflaro (USA), Zinforo (EU)

View Details
Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View Details
Omaveloxolone

Strength:
150 mg

Form: Tablets

Reference Brands: Skyclarys (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.